Mr. Speaker, I vehemently disagree with the member's comment of “all talk and no action”. In the 2020 Speech from the Throne and the fall economic statement, our government reaffirmed its commitment to accelerating steps to achieve national pharmacare, including developing a high-cost drugs for rare diseases strategy and establishing a national formulary.
Canadians are counting on us to get this right. It is important that we continue, as I said, with our measured and considered approach to its implementation and collaboration with provinces and territories and other key health system partners. In Canada, provinces and territories are responsible for their respective health care design and delivery. Our government respects the jurisdiction of provincial and territorial governments in this space.
We are committed to working closely with jurisdictions that are ready and willing to advance the implementation of national pharmacare. Now is the time to sit down with provinces and territories and commit to working together to provide all Canadians with access to affordable medications.